4/A//SEC Filing
Kim Dong 4/A
Accession 0001437749-24-003794
CIK 0001668243other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:47 PM ET
Size
4.7 KB
Accession
0001437749-24-003794
Insider Transaction Report
Form 4/AAmended
Kim Dong
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-01-31+3,333→ 35,253 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]This amendment corrects and restates the Amount of Securities Beneficially Owned Following Reported Transaction reported in the original Form 4 filed on February 2, 2024.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001920163
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:47 PM ET
- Size
- 4.7 KB